LIGAND PHARMACEUTICALS INCORPORATED Interest Income (Expense), Net
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Interest Income (Expense), Net of -$11.40 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2018-03-01
- LIGAND PHARMACEUTICALS INCORPORATED interest income (expense), net for fiscal 2017 was -$11.40M.
- LIGAND PHARMACEUTICALS INCORPORATED interest income (expense), net for fiscal 2016 was -$12.18M.
- LIGAND PHARMACEUTICALS INCORPORATED interest income (expense), net for fiscal 2015 was -$11.80M.
- LIGAND PHARMACEUTICALS INCORPORATED interest income (expense), net for fiscal 2014 was -$4.86M.
| Period end | Interest Income (Expense), Net 12 month | Interest Income (Expense), Net 12 month as first filed |
|---|---|---|
| 2017-12-31 | -$11.40M 10-K · filed 2018-03-01 | |
| 2016-12-31 | -$12.18M 10-K · filed 2018-03-01 | |
| 2015-12-31 | -$11.80M 10-K · filed 2018-03-01 | |
| 2014-12-31 | -$4.86M 10-K · filed 2017-02-28 | -$2.08M 10-K · filed 2014-12-01 |
| 2013-12-31 | -$2.08M 10-K · filed 2016-11-14 | |
| 2012-12-31 | -$2.92M 10-K · filed 2015-02-23 | -$3.31M 10-K · filed 2013-03-14 |
| 2011-12-31 | -$2.30M 10-K/A · filed 2014-12-12 | -$2.48M 10-K · filed 2013-03-14 |
| 2010-12-31 | $382.00K 10-K · filed 2013-03-14 |